Viewing Study NCT00051493


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2025-12-27 @ 11:53 PM
Study NCT ID: NCT00051493
Status: COMPLETED
Last Update Posted: 2006-07-19
First Post: 2003-01-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ALIMTA Plus Carboplatin as Front-Line Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
Sponsor: Eli Lilly and Company
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module